Download Now
Even at Centers of Excellence, nearly 50% of patients with a Class I or potential Class IIa indication for AVR do not receive treatment for severe aortic stenosis (AS).
Despite clear treatment pathways, disparities in care driven by geography, care setting, and provider type can leave patients vulnerable to underdiagnosis and undertreatment. Timely action is essential to prevent avoidable outcomes.
“Aortic stenosis is a deadly disease, and it really needs to be dealt with in an expeditious manner. When a patient has been delayed in their treatment, that becomes difficult to manage. [...] The options become very slim.” Vinod Thourani, MD | Cardiovascular Surgeon The Importance of Referring at the Right Time
“Aortic stenosis is a deadly disease, and it really needs to be dealt with in an expeditious manner. When a patient has been delayed in their treatment, that becomes difficult to manage. [...] The options become very slim.”
Vinod Thourani, MD | Cardiovascular Surgeon The Importance of Referring at the Right Time
Valve replacement IS SHOWN TO:
ONLY valve replacement can:
For a quick overview, download the ACC/AHA Guidelines One-Pager.
Once aortic stenosis progresses to severe AS, the window for intervention narrows rapidly.
Jumpstart the conversation about heart valve disease today.
PP--US-11785 v1.0
By clicking this link, you understand that the website that you will be taken to is not controlled or endorsed by Edwards Lifesciences (“Edwards”), and Edwards does not own, control, or influence the content found on the third-party website. You also understand that Edwards does not own or control any first- or third-party advertising, marketing, or analytics technologies that may be on the third-party website.
Would you like to continue?
The content on ScreenHeartValveDisease.com/hcp is intended for healthcare professionals.